Circulating BRAFV600E in the Diagnosis and Follow-Up of Differentiated Papillary Thyroid Carcinoma

摘要

Context:Cell-free nucleic acids circulating in plasma are considered a promising noninvasive tool for cancer monitoring. BRAF~(V600E) mutation in cell-free DNA (cfDNA) could represent an appropriate marker for papillary thyroid carcinoma (PTC).